Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Squadron Capital Management LLC

May 19, 2026 4:10 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Squadron Master Fund LP
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner, Squadron Partners LLC, its General Partner
Date:05/19/2026
Squadron Capital Management LLC
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner
Date:05/19/2026
Matthew Sesterhenn
Signature:/s/ Matthew Sesterhenn
Name/Title:Matthew Sesterhenn
Date:05/19/2026
William Blank
Signature:/s/ William Blank
Name/Title:William Blank
Date:05/19/2026

ATTACHMENTS / EXHIBITS

Squadron_ex1.pdf

Categories

SEC Filings